Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1

Genetics and Molecular Biology

Volumn 26, Issue 4, 2003, Pages 397-401

  Simon, Daniel ^a,b   Bandinelli, Eliane ^a   Roisenberg, Israel ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Genetics; Promoter polymorphisms; von Willebrand disease; von Willebrand factor

Indexed keywords

ADENINE; GUANINE; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE CONTROL; GENE FREQUENCY; GENE STRUCTURE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; RESTRICTION MAPPING; STATISTICAL SIGNIFICANCE; VON WILLEBRAND DISEASE;

EID: 0346097969     PISSN: 14154757     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1415-47572003000400001     Document Type: Article

References (34)

1. Castaman G, Eikenboom JCJ, Missiaglia E and Rodeghiero F (2000) Autossomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect. Br J Haematol 108:876-879.
2. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G and Wu KK (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) study. Thromb Haemost 70:380-385.
3. Coughlan TC, Blagg JL, Abulola M, Daly ME, Hampton KK, Makris M, Peake IR and Goodeve AC (1999) Null alleles are not a common cause of type 1 von Willebrand disease in the British population. Thromb Haemost 82:1373-1375.
4. Eikenboom JCJ, Reistma PH, Peerlinck KMJ and Briët E (1993) Recessive inheritance of von Willebrand's disease type 1. Lancet 341:982-986.
5. Eikenboom JCJ, Matsushita T, Reistma PH, Tuley EA, Castaman G, Briet E and Sadler JE (1996) Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood 88:2433-2442.
6. Eikenboom JCJ, Castaman G, Vos HL, Bertina RM and Rodeghiero F (1998) Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin. Thromb Haemost 79:709-717.
7. Favaloro EJ and Koutts J (1997) Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease. Pathology 29:385-391.
8. Fischer RR, Lucas EM, Pereira AMB and Roisenberg I (1996) Preparation of a heterologous antiserum for the determination of von Willebrand factor in human plasma. Braz J Med Biol Res 29:1641-1644.
9. Gill JC, Endres-Brooks J, Bauer PJ, Marks Jr WJ and Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691-1695.
10. Harvey PJ, Keightley AM, Lam YM, Cameron C and Lillicrap D (2000) A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels. Br J Haematol 109:349-353.
11. Heywood DM, Mansfield MW and Grant PJ (1996) Levels of von Willebrand factor, insulin resistance syndrome, and a common VWF gene polymorphism in non-insulin-dependent (type 2) diabetes mellitus. Diabetic Med 13:720-725.
12. Kadir RA, Economides DL, Sabin CA, Owens D and Lee C (1999) Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 82:1456-1461.
13. Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, Eikenboom JCJ, Bertina RM and Rosendaal FR (1998) Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost 79:323-327.
14. Kamphuisen PW, Eikenboom JCJ, Rosendaal FR, Koster T, Blann AD, Vos HL and Bertina RM (2001) High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. Br J Haematol 115:156-158.
15. Keeney S, Cumming A and Hay C (1999) Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease. Thromb Haemost 82:1446-1450.
16. Keightley AM, Lam YM, Brady JN, Cameron CL and Lillicrap D (1999) Variation at the von Willebrand factor (VWF) gene locus is associated with plasma VWF:Ag levels: identification of three novel single nucleotide polymorphisms in the VWF gene promoter. Blood 93:4277-4283.
17. Lacquemant C, Gaucher C, Delorme C, Chatellier G, Gallois Y, Rodier M, Passa P, Balkau B, Mazurier C, Marre M and Froguel P (2000) Association between high von Willebrand factor levels and the Thr789Ala VWF gene polymorphism but not with nephropathy in type I diabetes. Kidney Int 57:1437-1443.
18. Lahiri DK and Numberger JI Jr (1991) A rapid non-enzimatic method for preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
19. Levy G and Ginsburg D (2001) Getting at the variable expressivity of von Willebrand disease. Thromb Haemost 86:144-148.
20. Meena K, Marmot M and Brunner E (2000) Social determinants of von Willebrand factor: The Whitehall II study. Arterioscler Thromb Vasc Biol 20:1842-1847.
21. Mohlke KL and Ginsburg D (1997) von Willebrand disease and quantitative variation in von Willebrand factor. J Lab Clin Med 130:252-261.
22. Nichols WC and Ginsburg D (1997) von Willebrand disease. Medicine 76:1-20.
23. Rodeghiero F, Castaman G and Dini E (1987) Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 69:454-459.
24. Sadler JE (1994) A revised classification of von Willebrand disease. Thromb Haemost 71:520-525.
25. Sadler JE, Matsushita T, Dong Z, Tuley EA and Westfield LA (1995) Molecular mechanism and classification of von Willebrand disease. Thromb Haemost 74:161-166.
26. Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, Titani K, Katayama M, Yamamoto F and Yoshioka A (1995) ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 68:236-240.
27. Simon D, Palatnik M and Roisenberg I (2002) Analysis of the -1185A/G von Willebrand factor (VWF) gene polymorphism in two Brazilian ethnic groups and its effect on the plasma VWF levels. Thromb Res 105:519-522.
28. Souto JC, Almasy L, Muñiz-Diaz E, Soria JM, Borrell M, Bayen L, Mateo J, Madoz P, Stone W, Blangero J and Fontcuberta J (2000) Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 20:2024-2028.
29. Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, Blangero J and Fontcuberta J (2003) Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost 89:468-474.
30. Vischer UM, Emeis JJ, Bilo HJG, Stehouwer CDA, Thomsen C, Rasmussen O, Hermansen K, Wollheim CB and Ingerslev J (1998) von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Thromb Haemost 80:1002-1007.
31. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J and Abshire TC (1993) Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatric 123:893-898.
32. Zhang ZP, Lindstedt M, Falk G, Blombäck M, Egberg N and Anvret M (1992) Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I. Am J Hum Genet 51:850-858.
33. Zhang ZP, Blombäck M, Egberg N, Falk G and Anvret M (1994) Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin. Genomics 21:188-193.
34. Zhang ZP, Lindstedt M, Blombäck M and Anvret M (1995) Effects of the mutant von Willebrand factor gene in von Willebrand disease. Hum Genet 96:388-394.